Lv7
4969 积分 2022-09-03 加入
Letter to the editor: circulating tumor DNA as a biomarker for progression and survival in esophageal cancer after neoadjuvant therapy and esophagectomy: a systematic review and meta-analysis
1天前
待确认
Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer
11天前
已完结
Precision Oncology: 2025 in Review
11天前
已完结
Liquid biopsies across the cancer care continuum
25天前
已完结
Elevated ctDNA Tumor Fraction Is Associated with Improved Mutation Detection but Worse Overall Survival in Advanced Non-Small Cell Lung Cancer: a Lung-MAP Study
29天前
已完结
Concordance between tumor tissue and plasma DNA genotyping in the NCI-MATCH trial (EAY131)
29天前
已完结
LIBELULE: a randomized phase III study to evaluate the clinical relevance of early liquid biopsy in patients with suspicious metastatic lung cancer
30天前
已完结
Utilizing ctDNA to discover mechanisms of resistance to targeted therapies in patients with metastatic NSCLC: towards more informative trials
1个月前
已完结
Clinical benefit and cost of plasma-first next-generation sequencing in patients with newly diagnosed advanced non-small cell lung cancer in Ireland: The PLAN study
1个月前
已完结
Comparative analysis of genomic profiles between tissue-based and plasma-based next-generation sequencing in patients with non-small cell lung cancer
1个月前
已完结
皖公网安备34019202002308
